BAY-7081 是一种有效的、选择性的、具有口服活性的可溶性氰吡啶基PDE9A抑制剂,其IC50为 15 nM。
生物活性 | BAY-7081 is a potent, selective, orally active and soluble cyanopyridone-basedPDE9Ainhibitor with anIC50of 15 nM[1]. |
IC50& Target[1] | |
体内研究 (In Vivo) | BAY-7081 (0.3 or 1.0 mg/kg; i.v. or p.o.) 表现出良好的体内药代动力学特性[1]。
Animal Model: | Wistar rats and dogs[1] | Dosage: | 0.3 or 1.0 mg/kg | Administration: | Intravenous injection or oral (Pharmacokinetic Analysis) | Result: | PK Profile of PDE9A Inhibitor BAY-7081 in Selected Speciesa[1]
species | CLbb[L h–1 kg–1] | VSSc[L kg–1] | MRTd[h] | Fe[%] | Rat | 2.4 | 4.5 | 1.9 | 61 | Dog | 0.9 | 3.0 | 4.0 | 80 |
aValues were derived by intravenous (dose 0.3 mg/kg) and oral (dose 1.0 mg/kg) administration of solutions in either plasma 99% + DMSO 1% (rat iv) or EtOH/PEG400/H2O (dog iv, rat and dog po) vehicles. bBlood clearance. cVolume of distribution at steady state. dMean residence time after iv application. eOral bioavailability. |
|
分子量 | |
Formula | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |